Managed Healthcare Executive13h
Thirst-Quenching News. It's Time To Ditch Fluid Intake Restriction for Many Heart Failure Patients, Study Authors Say | ACC 2025
The largest randomized study of fluid intake restrictions showed no benefit from the restrictions, according to its senior ...
Onlymyhealth1d
Heart Attack Or A Broken Heart Syndrome: How To Tell The Difference
A heart attack and broken heart syndrome share similar symptoms But the two are separate conditions requiring distinct ...
For Pet's Sake: Understanding feline hypertrophic cardiomyopathy (HCM)
Feline Hypertrophic Cardiomyopathy (HCM) is the most common heart disease in cats, affecting felines of all breeds and ...
MPR2d
Amvuttra Gains Approval for Transthyretin Amyloid Cardiomyopathy
The Food and Drug Administration (FDA) has approved Amvuttra ® (vutrisiran) for the treatment of the cardiomyopathy of ...
FDA approves new drug to treat protein buildup in the heart
The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...
Beyonttra™ (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved in Japan to Treat ATTR-CM
In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-tolerated ...
BioPharma Dive10d
Alnylam drug gets long-awaited FDA approval in deadly heart disease
Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a ...
Medscape9d
FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy
The FDA has approved a supplemental new drug application for the treatment of cardiomyopathy wild-type or hereditary ...